References
- Yaniswari NMD, Amin M. Periostin serum level and asthma control test in Dr Soetomo General Hospital Surabaya. J Respirology. 2018;4(2): 33–37. doi:10.20473/jr.v4-I.2.2018.33-37
- Ramsahai JM, Hansbro PM, Wark PAB. Mechanisms and management of asthma exacerbations. American Journal of Respiratory and Critical Care Medicine. 2019;199(4): 423–432. doi:10.1164/rccm.201810-1931CI
- Liao H, Yang Z, Yang C, Tang Y, Liu S, Guan W, et al. Impact of viral infection on acute exacerbation of asthma in out-patient clinics: a prospective study. Journal of Thoracic Disease. 2016;8(3): 505–512. doi:10.21037/jtd.2016.02.76
- Wark PAB, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. European Respiratory Journal. 2002;19(1): 68–75. doi:10.1183/09031936.02.00226302
- Poulsen NN, Bjerregaard A, Khoo SK, Laing IA, Le Souёf P, Backer V, et al. Airway Interleukin-33 and type 2 cytokines in adult patients with acute asthma. Respiratory Medicine. 2018;140(January): 50–56. doi:10.1016/j.rmed.2018.05.016
- Xiao C, Puddicombe SM, Field S, Haywood J, Broughton-Head V, Puxeddu I, et al. Defective epithelial barrier function in asthma. The Journal of Allergy and Clinical Immunology. 2011;128(3): 549–556. doi:10.1016/j.jaci.2011.05.038
- Hossain FMA, Choi JY, Uyangaa E, Park SO, Eo SK. The interplay between host immunity and respiratory viral infection in asthma exacerbation. Immune Network. 2019;19(5): 1–21. doi:10.4110/in.2019.19.e31
- Wisnu Wardana VA, Rosyid AN. Inflammatory mechanism and clinical implication of asthma in COVID-19. Clin Med Insights Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine. 2021;15: 1–8. doi:10.1177/11795484211042711
- Jackson DJ, Makrinioti H, Rana BM, Shamji BW, Trujillo-Torralbo MB, Footitt J, et al. IL-33-Dependent type 2 inflammation duringrhinovirus-induced asthma exacerbations in vivo. American Journal of Respiratory and Critical Care Medicine. 2014;190(12): 1373–1382. doi:10.1164/rccm.201406-1039OC
- Donovan C, Bourke JE, Vlahos R. Targeting the IL-33/IL-13 axis for respiratory viral infections. Trends in Pharmacological Sciences. 2016;37(4): 252–261. doi:10.1016/j.tips.2016.01.004
- Zhu J, Message SD, Qiu Y, Mallia P, Kebadze T, Contoli M, et al. Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma. Chest. 2014;145(6): 1219–1229. doi:10.1378/chest.13-1567
- Ma Q, Qian Y, Jiang J, Wu J, Song M, Li X, et al. IL-33/ST2 axis deficiency exacerbates neutrophil-dominant allergic airway inflammation. Clinical & Translational Immunology. 2021;10(6): 1–18. doi:10.1002/cti2.1300
- Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. GINA (2019). Available from: www.ginasthma.org
- Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23(5): 479–490. doi:10.1016/j.immuni.2005.09.015
- Curren B, Ahmed T, Howard DR, Ashik Ullah M, Sebina I, Rash RB, et al. IL-33-induced neutrophilic inflammation and NETosis underlie rhinovirus-triggered exacerbations of asthma. Mucosal Immunology (2023) 16:671–684; doi: 10.1016/j. mucimm.2023.07.002
- Rank MA, Kobayashi T, Kozaki H, Bartemes KR, Squillace DL, Kita H. IL-33-activated dendritic cells induce an atypical TH2-type response. The Journal of Allergy and Clinical Immunology. 2009;123(5): 1047–1054. doi:10.1016/j.jaci.2009.02.026
- Fanny M, Nascimento M, Baron L, Schricke C, Maillet I, Akbal M, et al. The IL-33 receptor ST2 regulates pulmonary inflammation and fibrosis to bleomycin. Frontiers in Immunology. 2018;9(JUN): 1–12. doi:10.3389/fimmu.2018.01476
- Michaudel C, Mackowiak C, Maillet I, Fauconnier L, Akdis CA, Sokolowska M, et al. Ozone exposure induces respiratory barrier biphasic injury and inflammation controlled by IL-33. The Journal of Allergy and Clinical Immunology. 2018;142(3): 942–958. doi:10.1016/j.jaci.2017.11.044
- Alves-Filho JC, Sônego F, Souto FO, Freitas A, Verri WA Jr, Auxiliadora-Martins M, et al. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Natural Medicines. 2010;16(6): 708–712. doi:10.1038/nm.2156
- Saikumar Jayalatha AK, Hesse L, Ketelaar ME, Koppelman GH, Nawijn MC. The central role of IL-33/IL-1RL1 pathway in asthma: from pathogenesis to intervention. Pharmacology & Therapeutics. 2021;225: 107847. doi:10.1016/j.pharmthera.2021.107847
- Cohen ES, Scott IC, Majithiya JB, Rapley L, Kemp BP, England E, et al. Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation. Nature Communications. 2015;6: 1–10. doi:10.1038/ncomms9327
- Johnston SL, Pattemore PK, Sanderson G, Smith S, Campbell MJ, Josephs LK, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a timetrend analysis. American Journal of Respiratory and Critical Care Medicine. 1996;154(3 Pt 1): 654–660. doi:10.1164/ajrccm.154.3.8810601
- Sandrock CE, Norris A. Infection in severe asthma exacerbations and critical asthma syndrome. Clinical Reviews in Allergy & Immunology. 2015;48(1): 104–113. doi:10.1007/s12016-014-8435-x
- Bjerregaard A, Laing IA, Poulsen N, Backer V, Sverrild A, Fally M, et al. Characteristics associated with clinical severity and inflammatory phenotype of naturally occurring virus-induced exacerbations of asthma in adults. Respiratory Medicine. 2017;123: 34–41. doi:10.1016/j.rmed.2016.12.010
- Yamaya M. Virus infection-induced bronchial asthma exacerbation. Pulmonary Medicine. 2012;2012: 834826. doi:10.1155/2012/834826